FI108225B - Menetelmä uusien D-vitamiinianalogien valmistamiseksi - Google Patents

Menetelmä uusien D-vitamiinianalogien valmistamiseksi Download PDF

Info

Publication number
FI108225B
FI108225B FI952972A FI952972A FI108225B FI 108225 B FI108225 B FI 108225B FI 952972 A FI952972 A FI 952972A FI 952972 A FI952972 A FI 952972A FI 108225 B FI108225 B FI 108225B
Authority
FI
Finland
Prior art keywords
compound
formula
compounds
mixture
preparation
Prior art date
Application number
FI952972A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI952972A0 (fi
FI952972A (fi
Inventor
Gunnar Grue-Soerensen
Erik Rytter Ottosen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of FI952972A0 publication Critical patent/FI952972A0/fi
Publication of FI952972A publication Critical patent/FI952972A/fi
Application granted granted Critical
Publication of FI108225B publication Critical patent/FI108225B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI952972A 1992-12-23 1995-06-16 Menetelmä uusien D-vitamiinianalogien valmistamiseksi FI108225B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9226877 1992-12-23
GB929226877A GB9226877D0 (en) 1992-12-23 1992-12-23 Chemical compounds
DK9300425 1993-12-17
PCT/DK1993/000425 WO1994014766A1 (en) 1992-12-23 1993-12-17 Novel vitamin d analogues

Publications (3)

Publication Number Publication Date
FI952972A0 FI952972A0 (fi) 1995-06-16
FI952972A FI952972A (fi) 1995-06-16
FI108225B true FI108225B (fi) 2001-12-14

Family

ID=10727157

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952972A FI108225B (fi) 1992-12-23 1995-06-16 Menetelmä uusien D-vitamiinianalogien valmistamiseksi

Country Status (15)

Country Link
US (1) US5554599A (el)
EP (1) EP0675878B1 (el)
KR (1) KR100295977B1 (el)
AT (1) ATE148454T1 (el)
AU (1) AU668638B2 (el)
CA (1) CA2146775C (el)
DE (1) DE69307929T2 (el)
DK (1) DK0675878T3 (el)
ES (1) ES2098123T3 (el)
FI (1) FI108225B (el)
GB (1) GB9226877D0 (el)
GR (1) GR3022774T3 (el)
NZ (1) NZ259317A (el)
RU (1) RU2136660C1 (el)
WO (1) WO1994014766A1 (el)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830885A (en) * 1992-03-12 1998-11-03 The Johns Hopkins University Antiproliferative vitamin D3 hybrids
US20040167106A1 (en) * 1993-06-04 2004-08-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of a Vitamin D compound
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
GB9314400D0 (en) * 1993-07-12 1993-08-25 Leo Pharm Prod Ltd Produktionsaktieselskab) chemical compounds
US5824811A (en) * 1994-04-11 1998-10-20 Chugai Seiyaku Kabushiki Kaisha 22-Thiavitamin D3 derivatives
EP0870503B9 (en) * 1995-12-28 2006-06-28 Chugai Seiyaku Kabushiki Kaisha use of vitamin D derivatives for the manufacture of a medicament for treating MALIGNANT TUMOR METASTASIS
US6869940B2 (en) 1995-12-28 2005-03-22 Chugai Seiyaku Kabushiki Kaisha Malignant tumor metastasis inhibitors
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6184398B1 (en) 1996-12-20 2001-02-06 Chugai Seiyaku Kabushiki Kaisha 16-ene-vitamin D derivatives
IL130484A (en) * 1996-12-20 2004-07-25 Chugai Pharmaceutical Co Ltd History of -16N-Vitamin-D
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
DK1180035T3 (da) 1999-04-01 2007-03-05 Univ Johns Hopkins Ikke kalcemiske, antiproliferative, transkriptionsmæssigt aktive svovlholdige analoger af 1-alpha, 25-dihydroxy-vitamin D3
US6703380B2 (en) 1999-09-29 2004-03-09 Colotech A/S Prevention of cancer
ES2240159T3 (es) 1999-09-29 2005-10-16 Colotech A/S Prevencion del cancer colorrectal.
WO2001030751A2 (en) * 1999-10-25 2001-05-03 Strakan Limited USES OF 1,25-DIHYDROXY-5,6-trans VITAMIN D COMPOUNDS AND DERIVATIVES THEREOF
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
JP4803939B2 (ja) * 2000-04-19 2011-10-26 中外製薬株式会社 ビタミンｄ誘導体
CN100469764C (zh) 2000-06-15 2009-03-18 中外制药株式会社 维生素d衍生物
ATE428692T1 (de) * 2001-08-22 2009-05-15 Univ Johns Hopkins 24-schwefel-substituierte 1-alpha-25-dihydroxy- vitamin-d3-analogen
NZ531944A (en) 2001-10-19 2006-03-31 Isotechnika Inc Synthesis of cyclosporin analogs
ES2380748T3 (es) 2002-06-13 2012-05-18 Johns Hopkins University Compuestos de 24-sulfoximina vitamina D3
CA2510228C (en) 2002-12-18 2012-10-30 Johns Hopkins University 25-so2-substituted analogs of 1.alpha.,25-dihydroxyvitamin d3
MX339746B (es) 2009-01-27 2016-06-08 Berg Llc Vitamina d3 y análogos de la misma para aliviar efectos secundarios asociados con la quimioterapia.
JP5978130B2 (ja) 2009-08-14 2016-08-24 バーグ エルエルシー 脱毛症を治療するためのビタミンｄ３およびその類似体
WO2014194133A1 (en) 2013-05-29 2014-12-04 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2631025B1 (fr) * 1988-05-04 1991-04-12 Ire Medgenix Sa Nouveaux derives de la vitamine d3 et application aux dosages des metabolites de la vitamine d3
GB8904153D0 (en) * 1989-02-23 1989-04-05 Leo Pharm Prod Ltd Chemical compounds
US5824811A (en) * 1994-04-11 1998-10-20 Chugai Seiyaku Kabushiki Kaisha 22-Thiavitamin D3 derivatives

Also Published As

Publication number Publication date
CA2146775A1 (en) 1994-07-07
NZ259317A (en) 1997-05-26
WO1994014766A1 (en) 1994-07-07
ATE148454T1 (de) 1997-02-15
US5554599A (en) 1996-09-10
DK0675878T3 (da) 1997-04-28
FI952972A0 (fi) 1995-06-16
EP0675878A1 (en) 1995-10-11
DE69307929D1 (de) 1997-03-13
GB9226877D0 (en) 1993-02-17
FI952972A (fi) 1995-06-16
EP0675878B1 (en) 1997-01-29
KR100295977B1 (ko) 2001-11-14
DE69307929T2 (de) 1997-09-04
ES2098123T3 (es) 1997-04-16
KR950703501A (ko) 1995-09-20
AU668638B2 (en) 1996-05-09
GR3022774T3 (en) 1997-06-30
RU2136660C1 (ru) 1999-09-10
RU95113480A (ru) 1997-03-20
CA2146775C (en) 2005-06-28
AU5808794A (en) 1994-07-19

Similar Documents

Publication Publication Date Title
FI108225B (fi) Menetelmä uusien D-vitamiinianalogien valmistamiseksi
FI103791B (fi) Menetelmä ja välituote uusien D-vitamiinianalogien valmistamiseksi
FI106120B (fi) Menetelmä uusien D-vitamiinianalogien valmistamiseksi
FI106118B (fi) Menetelmä uusien D-vitamiinianalogien valmistamiseksi
FI109687B (fi) Menetelmä uusien D-vitamiinianalogien valmistamiseksi
FI92929B (fi) Menetelmä uusien farmaseuttisesti vaikuttavien vitamiini D analogien valmistamiseksi
JP3773253B2 (ja) 新規ビタミンｄ類似体
US5401732A (en) Vitamin D analogues
EP0506794B1 (en) Novel vitamin d analogues
FI109686B (fi) Menetelmä uusien D-vitamiinianalogien valmistamiseksi
FI108224B (fi) Menetelmä uusien D-vitamiinianalogien valmistamiseksi
KR20000057417A (ko) 비타민 ｄ3 유도체
JPH08504775A (ja) 新規ビタミンｄ類似体